patent expiry
Allergan launches Crestor generic in the US
May 3, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales
Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …
Lipitor losses hit Pfizer
May 2, 2012Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry
Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …
Prevnar and Lyrica lift Pfizer results
November 1, 2011Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry
Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter. …
Health service’s £1bn patent expiry windfall
October 14, 2011Sales and Marketing generics, patent expiry
Patent expiries could shave £1 billion from the NHS drugs bill, and could yield major savings by 2015 for the …
Lilly posts strong quarterly results, faces challenges ahead
July 22, 2011Sales and Marketing lilly, patent expiry
Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …
AstraZeneca revenues reach standstill
January 31, 2011Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results
AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …
Latest content
Five Facts about cardiovascular disease
